BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Encke J, Bernardin J, Geib J, Barbakadze G, Bujdoso R, Stremmel W. Genetic vaccination with Flt3-L and GM-CSF as adjuvants: Enhancement of cellular and humoral immune responses that results in protective immunity in a murine model of hepatitis C virus infection. World J Gastroenterol 2006; 12(44): 7118-7125 [PMID: 17131473 DOI: 10.3748/wjg.v12.i44.7118]
URL: https://www.wjgnet.com/1007-9327/full/v12/i44/7118.htm
Number Citing Articles
1
Rémi Vernet, Emily Charrier, Erika Cosset, Sabine Fièvre, Ugo Tomasello, Julien Grogg, Nicolas Mach. Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination ModelVaccines 2021; 9(5): 484 doi: 10.3390/vaccines9050484
2
Istvan Berczi, Andres Quintanar‐Stephano, Kalman Kovacs. Neuroimmune Regulation in Immunocompetence, Acute Illness, and HealingAnnals of the New York Academy of Sciences 2009; 1153(1): 220 doi: 10.1111/j.1749-6632.2008.03975.x
3
Meredith Hazen, Sunil Bhakta, Rajesh Vij, Steven Randle, Dara Kallop, Vicki Chiang, Isidro Hötzel, Bijay S Jaiswal, Karen E Ervin, Bing Li, Robby M Weimer, Paul Polakis, Richard H Scheller, Jagath R Junutula, Jo-Anne S Hongo. An improved and robust DNA immunization method to develop antibodies against extra-cellular loops of multi-transmembrane proteinsmAbs 2014; 6(1): 95 doi: 10.4161/mabs.26761
4
Takeshi Wada, Michinori Kohara, Yasuhiro Yasutomi. DNA vaccine expressing the non-structural proteins of hepatitis C virus diminishes the expression of HCV proteins in a mouse modelVaccine 2013; 31(50): 5968 doi: 10.1016/j.vaccine.2013.10.037
5
Cara K Fraser, Kerrilyn R Diener, Michael P Brown, John D Hayball. Improving vaccines by incorporating immunological coadjuvantsExpert Review of Vaccines 2007; 6(4): 559 doi: 10.1586/14760584.6.4.559
6
Jeffrey D. Ahlers, Igor M. Belyakov. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccinesTrends in Molecular Medicine 2009; 15(6): 263 doi: 10.1016/j.molmed.2009.04.003
7
O. V. Masalova, E. I. Lesnova, V. V. Grabovetskii, O. A. Smirnova, T. I. Ulanova, A. N. Burkov, A. V. Ivanov, A. D. Zaberezhnyi, R. I. Ataullakhanov, A. A. Kushch. DNA immunization with a plasmid carrying the gene of hepatitis C virus protein 5A (NS5A) induces an effective cellular immune responseMolecular Biology 2010; 44(2): 245 doi: 10.1134/S0026893310020093
8
Philip Wintermeyer, Jack R. Wands. Vaccines to prevent chronic hepatitis C virus infection: current experimental and preclinical developmentsJournal of Gastroenterology 2007; 42(6): 424 doi: 10.1007/s00535-007-2057-5
9
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative ReviewViruses 2023; 15(1): 214 doi: 10.3390/v15010214
10
István Berczi, Andrés Quintanar Stephano. Insights to Neuroimmune Biology2016; : 185 doi: 10.1016/B978-0-12-801770-8.00008-2
11
William K. Decker, Amar Safdar. Cytokine adjuvants for vaccine therapy of neoplastic and infectious diseaseCytokine & Growth Factor Reviews 2011; 22(4): 177 doi: 10.1016/j.cytogfr.2011.07.001
12
O. V. Masalova, E. I. Lesnova, L. N. Shingarova, V. L. Tunitskaya, T. I. Ulanova, A. N. Burkov, A. A. Kushch. The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor, and inhibitor of regulatory T cells induces effective immune responce against Hepatitis C virusMolecular Biology 2012; 46(3): 473 doi: 10.1134/S0026893312030077
13
Hongtao Kang, Yinglin Qi, Hualei Wang, Xuexing Zheng, Yuwei Gao, Nan Li, Songtao Yang, Xianzhu Xia. Chimeric Rabies Virus-Like Particles Containing Membrane-Anchored GM-CSF Enhances the Immune Response against Rabies VirusViruses 2015; 7(3): 1134 doi: 10.3390/v7031134
14
Ali Shayeghpour, Roya Kianfar, Parastoo Hosseini, Mehdi Ajorloo, Sepehr Aghajanian, Mojtaba Hedayat Yaghoobi, Tayebeh Hashempour, Sayed-Hamidreza Mozhgani. Hepatitis C virus DNA vaccines: a systematic reviewVirology Journal 2021; 18(1) doi: 10.1186/s12985-021-01716-8
15
Samaneh Karimkhanilouyi, Saeid Ghorbian. Nucleic acid vaccines for hepatitis B and C virusInfection, Genetics and Evolution 2019; 75: 103968 doi: 10.1016/j.meegid.2019.103968
16
Olga V. Masalova, Ekaterina I. Lesnova, Alexei V. Pichugin, Tatiana M. Melnikova, Vadim V. Grabovetsky, Natalia V. Petrakova, Olga A. Smirnova, Alexander V. Ivanov, Alexei D. Zaberezhny, Ravshan I. Ataullakhanov, Maria G. Isaguliants, Alla A. Kushch. The successful immune response against hepatitis C nonstructural protein 5A (NS5A) requires heterologous DNA/protein immunizationVaccine 2010; 28(8): 1987 doi: 10.1016/j.vaccine.2009.10.097
17
Peng Peng Ip, Hans W. Nijman, Jan Wilschut, Toos Daemen. Therapeutic vaccination against chronic hepatitis C virus infectionAntiviral Research 2012; 96(1): 36 doi: 10.1016/j.antiviral.2012.07.006
18
K. Schautteet, E. Stuyven, D.S.A. Beeckman, S. Van Acker, M. Carlon, K. Chiers, E. Cox, D. Vanrompay. Protection of pigs against Chlamydia trachomatis challenge by administration of a MOMP-based DNA vaccine in the vaginal mucosaVaccine 2011; 29(7): 1399 doi: 10.1016/j.vaccine.2010.12.042
19
Ioana Ghita, Evangelia Piperi, Sergei P. Atamas, Soren M. Bentzen, Robert A. Ord, Donita Dyalram, Joshua E. Lubek, Rania H. Younis. Cytokine profiling in plasma distinguishes the histological inflammatory subtype of head and neck squamous cell carcinoma and a novel regulatory role of osteopontinFrontiers in Oral Health 2022; 3 doi: 10.3389/froh.2022.993638
20
Michael G. Tovey, Christophe Lallemand. Vaccine AdjuvantsMethods in Molecular Biology 2010; 626: 287 doi: 10.1007/978-1-60761-585-9_19